Revenue (Tables)

9 Months Ended

Sep. 30, 2018

Revenue from Contract with Customer [Abstract]

Impact of ASC 606 in Current Period [Table Text Block]

The following tables represent the amounts by which each financial statement line item is affected in the current year as a result of applying ASC Topic 606 (in thousands):



	For the three months ended September 30, 2018							For the nine months ended September 30, 2018
	As Reported		Without Adoption of ASC 606		Effect of Adoption			As Reported		Without Adoption of ASC 606		Effect of Adoption
Revenue	$	327,169	$	340,671	$	(13,502	)	$	1,059,662	$	1,062,980	$	(3,318	)
Cost of goods sold	$	192,582	$	196,159	$	(3,577	)	$	624,274	$	626,810	$	(2,536	)
Gross Profit	$	134,587	$	144,512	$	(9,925	)	$	435,388	$	436,170	$	(782	)



	As of September 30, 2018
	As Reported	Without Adoption of ASC Topic 606		Effect of Adoption
Prepaid expenses and other current assets	26,306	$	26,872	$	(566	)
Accrued liabilities	131,954	$	140,107	$	(8,153	)
Deferred income taxes	20,341	$	22,340	$	(1,999	)

Disaggregation of Revenue [Table Text Block]

The following table represents our revenues disaggregated by geography (in thousands):



	For the three months ended September 30,				For the nine months ended September 30,
Geography	2018		2017 ⁽¹⁾		2018		2017 ⁽¹⁾
EMEA	$	30,759	$	31,034	$	104,150	$	87,892
APAC	17,779		16,982		54,813		44,071
LATAM	16,051		16,349		44,701		42,034
North America	17,739		21,939		54,684		50,037
Other	—		120		80		120
Total Foreign	82,328		86,424		258,428		224,154
United States	244,841		256,812		801,234		698,335
Total Revenues	$	327,169	$	343,236	$	1,059,662	$	922,489

The following table represents our revenues disaggregated by product (in thousands):



	For the three months ended September 30,				For the nine months ended September 30,
Product line	2018		2017 ⁽¹⁾		2018		2017 ⁽¹⁾
Infusion Consumables	$	117,797	$	92,612	$	361,490	$	245,885
IV Solutions	114,433		143,710		394,198		375,494
Infusion Systems ⁽²⁾	81,456		82,798		263,271		202,590
Critical Care	13,483		12,950		40,703		37,221
Other	—		11,166		—		61,299
Total Revenues	$	327,169	$	343,236	$	1,059,662	$	922,489

Contract with Customer, Asset and Liability [Table Text Block]

The following table presents our changes in the contract balances for the nine months ended September 30, 2018 (in thousands):



	Contract Liabilities
Beginning balance, January 1, 2018	$	(7,066	)
Equipment revenue recognized	3,136
Equipment revenue deferred due to implementation	(4,086		)
Software revenue recognized	5,649
Software revenue deferred due to implementation	(5,507		)
Ending balance, September 30, 2018	$	(7,874	)